Biohaven Research Ltd. (CIK: 0001935979) EDGAR, Information, Filings... CompaniesBIO.Com

Biohaven Research Ltd.

Mailing address
215 CHURCH STREET, NEW HAVEN, Virgin Islands, British, 06510
Phone
203-404-0410
State location
Connecticut
State of incorporation
Virgin Islands, British
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Biohaven Research Ltd. (CIK: 0001935979) is an American company incorporated in the state of Connecticut. Head office is located at 215 CHURCH STREET, NEW HAVEN, Connecticut, 06510. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Biohaven Research Ltd. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Clark George C.	0001878290	Nov-08-2022	officer: VP, Chief Accounting Officer
CHILDS JOHN W	0001027035	Oct-03-2022	director
GREGORY JULIA P	0001226675	Oct-03-2022	director
HUGIN ROBERT J	0001232505	Oct-03-2022	director
Bailey Gregory	0001329505	Oct-03-2022	director
Heffernan Michael Thomas	0001448914	Oct-03-2022	director
Biohaven Pharmaceutical Holding Co Ltd.	0001689813	Oct-03-2022	10 percent owner
Gentile Kimberly	0001704186	Oct-03-2022	officer: SVP, Clinical Operations
Coric Vlad	0001704317	Oct-03-2022	director, officer: Chief Executive Officer
Mehta Kishan	0001850520	Oct-03-2022	director
Buten Matthew	0001898799	Oct-03-2022	officer: Chief Financial Officer
Antonijevic Irina	0001926476	Oct-03-2022	director
Car Bruce	0001798876	Sep-28-2022	officer: Chief Scientific Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Biohaven Research Ltd.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001935979-26-000048 (34 Act) Size: KB	May-27-2026	001-41477 261027517
SCHEDULE 13G/A	Document	Acc-no: 0001274173-26-000140 (34 Act) Size: KB	May-15-2026	005-93806 26984903
8-K	Document	Current report filing Acc-no: 0001628280-26-030579 (34 Act) Size: KB	May-05-2026	001-41477 26943485
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001628280-26-029924 (33 Act) Size: KB	May-04-2026	333-295531 26938948
S-3ASR	Document	Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001628280-26-029834 (33 Act) Size: KB	May-04-2026	333-295531 26938015
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001935979-26-000045 (34 Act) Size: KB	May-04-2026	001-41477 26937567
8-K	Document	Current report filing Acc-no: 0001935979-26-000044 (34 Act) Size: KB	May-04-2026	001-41477 26937531
8-K	Document	Current report filing Acc-no: 0001935979-26-000042 (34 Act) Size: KB	May-04-2026	001-41477 26937347
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001850520-26-000005 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001329505-26-000005 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001448914-26-000002 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001926476-26-000002 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001027035-26-000008 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001232505-26-000003 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001226675-26-000002 ( Act) Size: 0 KB	Apr-30-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001850520-26-000003 ( Act) Size: 0 KB	Mar-19-2026
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001935979-26-000030 (34 Act) Size: KB	Mar-13-2026	001-41477 26753274
DEF 14A	Document	Definitive proxy statements Acc-no: 0001935979-26-000028 (34 Act) Size: KB	Mar-13-2026	001-41477 26753243
4/A	Document	Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001027035-26-000006 ( Act) Size: KB	Mar-09-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001898799-26-000004 ( Act) Size: 0 KB	Mar-03-2026

Recent 20 filings. View all Biohaven Research Ltd. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Biohaven Research Ltd. overview
Biohaven Research Ltd. job
Biohaven Research Ltd. stock
Biohaven Research Ltd. ownership
Biohaven Research Ltd. CEO
Biohaven Research Ltd. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.